If you have shopped for an NAD+ supplement, you have seen two acronyms compete for your attention: NMN and NR. They are close cousins, and the internet loves to declare one a clear winner. The honest answer is more nuanced.
The one-line difference
Both are precursors your body converts into NAD+. The difference is where they sit on the assembly line:
- NR (nicotinamide riboside) is one step further upstream. Inside the cell, NR is converted into NMN…
- NMN is then the final step before NAD+ itself.
So NR → NMN → NAD+. They travel the same road; they just get on at slightly different points.
What the human evidence looks like
NMN. Randomised, placebo-controlled trials have shown NMN can raise the blood NAD+/NADH ratio (Frontiers in Aging, 2022) and improve muscle insulin sensitivity in a specific population (Yoshino et al., Science, 2021).
NR. NR also has published human trials showing it reliably raises blood NAD+ and is generally well tolerated. The broader in-vivo evidence for NAD-boosting molecules is reviewed by Rajman, Chwalek & Sinclair (Cell Metabolism, 2018).
So which should you take?
For most people, the choice of a quality product matters more than NMN-vs-NR. What actually separates a good supplement from a bad one is dose (is it in the studied range?), purity (is it what the label says?), and verification (can you see third-party lab results?).
Where we land
We built our formula around NMN because it is the final step before NAD+ and has a growing base of randomised human trials at doses we can match honestly. Our NMN+ Daily Longevity uses a clinically studied NMN ingredient at a researched dose, and every batch is third-party tested with results on our Lab Reports page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not medical advice.